Selective PDE inhibitors as novel treatments for respiratory diseases

CP Page, D Spina - Current opinion in pharmacology, 2012 - Elsevier
Phosphodiesterases (PDEs) are a family of enzymes which catalyse the metabolism of the
intracellular cyclic nucleotides, c-AMP and c-GMP that are expressed in a variety of cell …
被引用次数：172 相关文章

[引用][C] Selective PDE inhibitors as novel treatments for respiratory diseases

CP Page, D Spina - Current Opinion in Pharmacology, 2012 - cir.nii.ac.jp

Selective PDE inhibitors as novel treatments for respiratory diseases.

CP Page, D Spina - Current Opinion in Pharmacology, 2012 - europepmc.org
Phosphodiesterases (PDEs) are a family of enzymes which catalyse the metabolism of the
intracellular cyclic nucleotides, c-AMP and c-GMP that are expressed in a variety of cell …

Selective PDE inhibitors as novel treatments for respiratory diseases

CP Page, D Spina - Current Opinion in Pharmacology, 2012 - kclpure.kcl.ac.uk
Phosphodiesterases (PDEs) are a family of enzymes which catalyse the metabolism of the
intracellular cyclic nucleotides, c-AMP and c-GMP that are expressed in a variety of cell …

Selective PDE inhibitors as novel treatments for respiratory diseases

CP Page, D Spina - Current opinion in pharmacology, 2012 - pubmed.ncbi.nlm.nih.gov
Phosphodiesterases (PDEs) are a family of enzymes which catalyse the metabolism of the
intracellular cyclic nucleotides, c-AMP and c-GMP that are expressed in a variety of cell …

Selective PDE inhibitors as novel treatments for respiratory diseases

CP Page, D Spina - Current Opinion in Pharmacology, 2012 - infona.pl
Phosphodiesterases (PDEs) are a family of enzymes which catalyse the metabolism of the
intracellular cyclic nucleotides, c-AMP and c-GMP that are expressed in a variety of cell …